◆英語タイトル：TearLab Corp (TEAR) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7031
◆発行会社（調査会社）：
GlobalData
◆発行日：2018年10月
◆ページ数：33
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.
TearLab Corp (TEAR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearLab Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
TearLab Completes Acquisition Of Assets Of OcuHub Business Unit From AOAExcel For US$1.4 Million 10
Equity Offering 11
TearLab to Raise USD3 Million in Private Placement of Securities 11
TearLab Files Registration Statement for Public Offering of Units of up to USD15 Million 12
TearLab Files Registration Statement for Public Offering of Shares and Warrants 13
TearLab Raises USD17.3 Million in Public Offering of Shares and Warrants 14
TearLab Withdraws Public Offering of Shares for up to USD15 Million 15
TearLab Completes Public Offering Of Shares For US$40.4 Million 17
TearLab Completes Private Placement Of Shares For US$8 Million 18
TearLab Completes Public Offering Of Common Stock For US$12.4 Million 19
TearLab Completes Private Placement Of Shares For US$2.56 Million Upon Exercise Of Warrants 21
TearLab Corp – Key Competitors 22
TearLab Corp – Key Employees 23
TearLab Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 09, 2018: Tearlab reports second quarter and first half 2018 financial results 25
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results 26
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 13, 2017: TearLab Reports Third Quarter and September Year-To-Date 2017 Financial Results 28
Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results 29
May 15, 2017: TearLab Corporation Reports First Quarter 2017 Financial Results 30
Mar 09, 2017: TearLab Corporation Reports Fourth Quarter and Year End 2016 31
Legal and Regulatory 32
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
TearLab Corp, Medical Equipment, Key Facts, 2017 2
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Deals By Market, 2012 to YTD 2018 8
TearLab Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearLab Completes Acquisition Of Assets Of OcuHub Business Unit From AOAExcel For US$1.4 Million 10
TearLab to Raise USD3 Million in Private Placement of Securities 11
TearLab Files Registration Statement for Public Offering of Units of up to USD15 Million 12
TearLab Files Registration Statement for Public Offering of Shares and Warrants 13
TearLab Raises USD17.3 Million in Public Offering of Shares and Warrants 14
TearLab Withdraws Public Offering of Shares for up to USD15 Million 15
TearLab Completes Public Offering Of Shares For US$40.4 Million 17
TearLab Completes Private Placement Of Shares For US$8 Million 18
TearLab Completes Public Offering Of Common Stock For US$12.4 Million 19
TearLab Completes Private Placement Of Shares For US$2.56 Million Upon Exercise Of Warrants 21
TearLab Corp, Key Competitors 22
TearLab Corp, Key Employees 23
TearLab Corp, Subsidiaries 24
List of Figures
TearLab Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearLab Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TearLab Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearLab Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
